Erratum
After publication of [1] it came to the authors’ attention that Frauke Naumann-Winter’s name was displayed incorrectly. The correct spelling of their name is included in this erratum.
Footnotes
The online version of the original article can be found under doi:10.1186/s13023-014-0175-8.
Contributor Information
Stelios Tsigkos, Email: Stylianos.Tsigkos@ema.europa.eu.
Segundo Mariz, Email: segundo.mariz@ema.europa.eu.
Jordi Llinares, Email: jordi.llinares@ema.europa.com.
Laura Fregonese, Email: laura.fregonese@ema.europa.eu.
Stiina Aarum, Email: stiina.aarum@ema.europa.eu.
Frauke Naumann-Winter, Email: Frauke.Naumann-Winter@bfarm.de.
Kerstin Westermark, Email: kerstin.westermark@mpa.se.
Bruno Sepodes, Email: bruno.sepodes@ema.europa.eu.
References
- 1.Tsigkos S, Mariz S, Llinares J, Fregonese L, Aarum S, Frauke N, Westermark K, Sepodes B. Establishing medical plausibility in the context of orphan medicines designation in the European Union. Orphanet Journal of Rare Diseases. 2014;9:175. doi: 10.1186/s13023-014-0175-8. [DOI] [PMC free article] [PubMed] [Google Scholar]